US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.865
  • +0.193+28.71%
Close Jul 26 16:00 ET
  • 0.885
  • +0.020+2.32%
Post 20:01 ET
179.48MMarket Cap-462P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

481.00K

-99.70%
EPS(YoY)

-0.27

-325.00%
Analyst Rating

Strong Buy

Jun 30, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.267M--
--2024/Q2-- / 6.883M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.267M--
--2024/Q2-- / 6.883M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

  • Sangamo Therapeutics | 10-Q: Quarterly report

    May 9 16:10 ET

  • Sangamo Therapeutics | 10-K: Annual report

    Mar 13 07:53 ET

  • Sangamo Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:17 ET

  • Sangamo Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.95%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.11%